Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

Biosergen AB: BioStock: Biosergen's CEO on the latest advancements

Biosergen

As fungal infections continue to be recognized as a growing global health problem, Biosergen is sharpening its focus. The company's recently published annual report highlights the clinical progress made in 2024 and its priorities in addressing an area with significant unmet medical needs. We contacted CEO Tine Olesen for a comment.  

Read the interview at biostock.se:

https://www.biostock.se/en/2025/05/biosergens-ceo-on-the-latest-advancements/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.